Woodworth Emily
SEC CIK 2013518 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | SVP, CAO, Gbl Ctrl | 2,930 | — | $1.92M | 17 | 2024-11-27 | 2026-08-11 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
| 11 | Woodworth Emily | SVP, CAO, Gbl Ctrl | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-12 16:08 | 2026-08-11 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | I - Discretionary | $51.19 | +2,930 | 2,930 | New | +$150.0K |
| D | 2026-03-03 | 2026-03-01 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +838 | 3,231 | +35% | $0 |
| D | 2026-03-03 | 2026-03-01 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $76.85 | -372 | 2,859 | -12% | -$28.6K |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +2,711 | 2,335 | New | $0 |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $74.73 | -1,269 | 2,393 | -35% | -$94.8K |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +481 | 1,193 | +68% | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $74.12 | -242 | 951 | -20% | -$17.9K |
| D | 2025-03-05 | 2025-03-03 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $37.50 | +5,949 | 8,063 | +281% | +$223.1K |
| DM | 2025-03-05 | 2025-03-03+ | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale+OE | $104.95 | -7,631 | 432 | -95% | -$800.9K |
| DM | 2025-03-03 | 2025-02-28+ | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $37.78 | +8,055 | 11.5K | +233% | +$304.3K |
| D | 2025-03-03 | 2025-02-28 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale+OE | $101.13 | -9,887 | 1,632 | -86% | -$999.9K |
| D | 2025-03-03 | 2025-03-01 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $103.79 | -355 | 2,114 | -14% | -$36.8K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $106.11 | -869 | 4,301 | -17% | -$92.2K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +1,964 | 4,584 | +75% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $105.77 | -231 | 3,206 | -7% | -$24.4K |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +480 | 3,437 | +16% | $0 |
| 2024-12-02 | 2024-11-27 | BSX | Boston Scientific | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale | $90.65 | -1,336 | 2,957 | -31% | -$121.1K |
Purchase Sale Sale after option exercise All abbreviations